我们相信被获准用于治疗双相障碍的药物越来越多可能会影响一部分临床医生。 他们不能判定一个病人是患了双相障碍还是边缘人格障碍就会错误地将病人诊断为对药物有反应的某种障碍。
We believe that the increased availability of medications that have been approved for the treatment of bipolar disorder might be influencing clinicians who are unsure whether or not a patient has bipolar disorder or borderline personality disorder to err on the side of diagnosing the disorder that is responsive to medication.